Browse by Speaker

Type here to filter the list

G
Gómez-Pérez, Beatriz

"La Arrixaca" Clinical University Hospital
Paper 68 - CHARACTERISTICS, APPLICATIONS, UTILITY AND USABILITY OF 3D MODELS IN HIGH COMPLEXITY SURGICAL ONCOLOGY. A READY-TO-USE TECHNOLOGY.
Beatriz Gómez-Pérez
Favorite
Gala, Kunal

Tata Memorial Centre
Paper 79 - EVALUATION OF METRONOMIC THERAPY AS A LOW-COST, SUSTAINABLE STANDARD OF CARE OPTION IN DESMOID FIBROMATOSIS: REAL WORLD DATA FROM A TERTEARY CARE CENTRE IN INDIA
Kunal Gala
Favorite
Gallego, Soledad

Vall d'Hebron Research Institute
Paper 33 - ASSESSING THE ROLE OF DIFFUSION-WEIGHTED MR IMAGING IN PEDIATRIC AND ADOLESCENT RHABDOMYOSARCOMA: AN INTERNATIONAL RETROSPECTIVE STUDY ON BEHALF OF THE EPSSG IMAGING COMMITTEE
Soledad Gallego
Favorite
Galor, Alon

University of Oxford, Wellcome Centre for Human Genetics
Paper 07 - CLINICAL AND GENOMIC PROGNOSTIC FACTORS IN MALIGNANT PERIPHERAL NERVE SHEATH TUMORS: INSIGHTS GAINED THROUGH THE GENOMICS OF MPNST CONSORTIUM
Alon Galor
Favorite
Ganjoo, Kristen

Stanford Cancer Center, Stanford University
Paper 22 - P10015/SARC033: A PHASE 2 TRIAL OF TRAMETINIB IN PATIENTS WITH ADVANCED EPITHELIOID HEMANGIOENDOTHELIOMA
Kristen Ganjoo
Favorite
Paper 49 - INTERACTIONS IN CSF1-DRIVEN TENOSYNOVIAL GIANT CELL TUMORS
Kristen Ganjoo
Favorite
Paper 61 - FINAL ANALYSIS FROM SPEARHEAD-1 COHORT 1 OF AFAMITRESGENE AUTOLEUCEL (“AFAMI-CEL” [FORMERLY ADP-A2M4]) IN ADVANCED SYNOVIAL SARCOMA AND MYXOID/ROUND CELL LIPOSARCOMA
Kristen Ganjoo
Favorite
Garcia Ortega, Dorian

National Cancer Institute (Mexico)
Paper 67 - CONVERSION OF RETROPERITONEAL WELL-DIFFERENTIATED TO DEDIFFERENTIATED LIPOSARCOMA: A TARPSWG NATURAL HISTORY STUDY
Dorian Garcia Ortega
Favorite
Garcia-Ortega, Dorian

National Cancer Institute Mexico
Paper 71 - SUBTYPE-RELATED RESPONSE TO ISOLATED LIMB PERFUSION IN SOFT TISSUE SARCOMAS
Dorian Garcia-Ortega
Favorite
Garrido-Laguna, Ignacio

Huntsman Cancer Institute at the University of Utah
Paper 23 - UPDATED EFFICACY AND SAFETY OF ENTRECTINIB IN PATIENTS WITH NTRK FUSION-POSITIVE SARCOMAS
Ignacio Garrido-Laguna
Favorite
Gaspar, Nathalie

Gustave Roussy
Paper 51 - PAIRWISE COMPARISONS OF THE FOUR CHEMOTHERAPY REGIMENS INITIALLY INCLUDED IN THE REECUR TRIAL FOR THE TREATMENT OF PRIMARY REFRACTORY AND RECURRENT EWING SARCOMA (RR-ES)
Nathalie Gaspar
Favorite
Gatenby, Bob

Moffitt
Paper 06 - EVOLUTIONARY TUMOR BOARD (NCT04343365) AS A MODEL FOR MOVING FORWARD: METASTATIC EWING SARCOMA
Bob Gatenby
Favorite
Gaunt, Piers

University of Birmingham
Paper 51 - PAIRWISE COMPARISONS OF THE FOUR CHEMOTHERAPY REGIMENS INITIALLY INCLUDED IN THE REECUR TRIAL FOR THE TREATMENT OF PRIMARY REFRACTORY AND RECURRENT EWING SARCOMA (RR-ES)
Piers Gaunt
Favorite
Gazendam, Aaron

McMaster University
Paper 73 - RISK FACTORS FOR ALL-CAUSE EARLY RE-OPERATIONS IN PATIENTS UNDERGOING TUMOR RESECTION AND ENDOPROSTHETIC RECONSTRUCTION: A SECONDARY ANALYSIS FROM THE PARITY TRIAL
Aaron Gazendam
Favorite
Gelderblom, Hans

Leiden University Medical Center, Leiden, Netherlands
Mentorship Session 9: How to Get Your Paper Published
Hans Gelderblom
Favorite
Paper 43 - A NOVEL PROGNOSTICATION SYSTEM FOR PATIENTS WITH HIGH-RISK KIT EXON 9-MUTATED GASTROINTESTINAL STROMAL TUMOUR RECEIVING ADJUVANT IMATINIB
Hans Gelderblom
Favorite
Paper 47 - LONG-TERM EFFICACY AND SAFETY OF PEXIDARTINIB IN PATIENTS WITH TENOSYNOVIAL GIANT CELL TUMOR: RESULTS FROM THE PHASE 3 ENLIVEN STUDY
Hans Gelderblom
Favorite
Paper 48 - INTRA-ARTICULAR INJECTIONS OF AMB-05X, A POTENT, SELECTIVE, HUMAN MONOCLONAL ANTIBODY AGAINST COLONY STIMULATING FACTOR 1 RECEPTOR FOR THE TREATMENT OF TENOSYNOVIAL GIANT CELL TUMOR
Hans Gelderblom
Favorite
Paper 51 - PAIRWISE COMPARISONS OF THE FOUR CHEMOTHERAPY REGIMENS INITIALLY INCLUDED IN THE REECUR TRIAL FOR THE TREATMENT OF PRIMARY REFRACTORY AND RECURRENT EWING SARCOMA (RR-ES)
Hans Gelderblom
Favorite
Paper 94 - GENOMIC ALTERATIONS OF DNA DAMAGE REPAIR PATHWAYS IN CHORDOMA: AN ANALYSIS FROM THE AACR-GENIE DATABASE
Hans Gelderblom
Favorite
Geng, Junxian

Boehringer Ingelheim Pharmaceuticals, Inc.
Paper 19 - A PHASE IA/IB, DOSE-ESCALATION/EXPANSION STUDY OF THE MDM2–P53 ANTAGONIST BI 907828 IN PATIENTS WITH SOLID TUMORS, INCLUDING ADVANCED/METASTATIC LIPOSARCOMA
Junxian Geng
Favorite
Geoerger, Birgit

Gustave Roussy Cancer Center, Department of Pediatric and Adolescent Oncology, Université Paris-Saclay, INSERM U1015
Paper 24 - LONG-TERM EFFICACY AND SAFETY OF LAROTRECTINIB IN PEDIATRIC PATIENTS WITH TROPOMYOSIN RECEPTOR KINASE FUSION SARCOMAS
Birgit Geoerger
Favorite
Paper 25 - DISCONTINUATION OF LAROTRECTINIB PRIOR TO DISEASE PROGRESSION IN PEDIATRIC SARCOMA: UPDATED ANALYSIS FROM SCOUT TRIAL
Birgit Geoerger
Favorite
George, Suzanne

Dana-Farber Cancer Institute
Paper 26 - NHEJ DEPENDENCE CREATES THERAPEUTIC VULNERABILITY IN LEIOMYOSARCOMA
Suzanne George
Favorite
Paper 36 - INCREASED PROGRESSION FREE SURVIVAL (PFS) IN ADVANCED GASTROINTESTINAL STROMAL TUMOR (GIST) PATIENTS TREATED WITH SUNITINIB AFTER CIRCULATING TUMOR DNA DETECTION OF A KIT EXON 13 RESISTANCE MUTATION
Suzanne George
Favorite
Gerrand, Craig

Royal National Orthopaedic Hospital NHS Trust
Paper 70 - SARCOSIGHT: A RANDOMIZED-CONTROL TRIAL OF FLUORESCENCE GUIDED SARCOMA SURGERY VERSUS THE STANDARD OF CARE
Craig Gerrand
Favorite
Ghert, Michelle

McMaster University
Paper 73 - RISK FACTORS FOR ALL-CAUSE EARLY RE-OPERATIONS IN PATIENTS UNDERGOING TUMOR RESECTION AND ENDOPROSTHETIC RECONSTRUCTION: A SECONDARY ANALYSIS FROM THE PARITY TRIAL
Michelle Ghert
Favorite
Gil, Elena

“La Arrixaca” Clinical University Hospital
Paper 68 - CHARACTERISTICS, APPLICATIONS, UTILITY AND USABILITY OF 3D MODELS IN HIGH COMPLEXITY SURGICAL ONCOLOGY. A READY-TO-USE TECHNOLOGY.
Elena Gil
Favorite
Gillis, Taylor

School of Medicine, University of Nevada Las Vegas
Paper 57 - HIGH-THROUGHPUT DRUG SCREENING IDENTIFIES GSK3B INHIBITION AS A THERAPEUTIC TARGET TO ENHANCE ALLOGENEIC NK CELL CYTOTOXICITY IN EWING SARCOMA
Taylor Gillis
Favorite
Gill, Jonathan

The University of Texas MD Anderson Cancer Center
Paper 89 - A PHASE 1/2 TRIAL OF GEMCITABINE, DOCETAXEL, AND HYDROXYCHLOROQUINE IN ADVANCED/METASTATIC OSTEOSARCOMA: RESULTS OF PHASE 1
Jonathan Gill
Favorite
Gil-Vazquez, Pedro J

"La Arrixaca" Clinical University Hospital
Paper 68 - CHARACTERISTICS, APPLICATIONS, UTILITY AND USABILITY OF 3D MODELS IN HIGH COMPLEXITY SURGICAL ONCOLOGY. A READY-TO-USE TECHNOLOGY.
Pedro J Gil-Vazquez
Favorite
Gimarc, David

Department of Radiology, University of Colorado School of Medicine - Anschutz Medical Campus
Paper 78 - A MULTICENTER RETROSPECTIVE EVALUATION OF THE FEASIBILITY AND RADIOLOGICAL AND CLINICAL OUTCOMES OF CRYO-ABLATION THERAPY FOR EXTRA-ABDOMINAL DESMOID
David Gimarc
Favorite
Giraudo, C.

Institute of Radiology, Department of Medicine-DIMED, University of Padova
Paper 33 - ASSESSING THE ROLE OF DIFFUSION-WEIGHTED MR IMAGING IN PEDIATRIC AND ADOLESCENT RHABDOMYOSARCOMA: AN INTERNATIONAL RETROSPECTIVE STUDY ON BEHALF OF THE EPSSG IMAGING COMMITTEE
C. Giraudo
Favorite
Gitelis, Steven

Rush University Medical Center
Paper 82 - DEVELOPMENT AND EXTERNAL VALIDATION OF A MACHINE LEARNING MODEL FOR PREDICTION OF SURVIVAL IN UNDIFFERENTIATED PLEOMORPHIC SARCOMA
Steven Gitelis
Favorite
Gladdy, Rebecca

Department of Surgery, Mount Sinai Hospital; Department of Surgery, University of Toronto; Department of Surgical Oncology, Princess Margaret Cancer Centre, University of Toronto; CanSaRCC, Princess Margaret Cancer Centre, Toronto
Mentorship Session 6: Wellness/Work Life Balance
Rebecca Gladdy
Favorite
Session 10: Retroperitoneal and Abdominal Sarcomas
Location: VCC, East Exhibition Hall A
Rebecca Gladdy
Favorite
Session 11: Surgery (Orthopedic, Reconstructive)
Location: VCC, East Exhibition Hall A
Rebecca Gladdy
Favorite
Session 2: Sarcoma Biology & 'omics
Location: VCC, East Exhibition Hall A
Rebecca Gladdy
Favorite
Paper 32 - ESTABLISHMENT OF HIGH-GRADE SOFT TISSUE SARCOMA METASTATIC DISEASE MURINE MODELS
Rebecca Gladdy
Favorite
Paper 62 - WHY DO PATIENTS WITH NON-METASTATIC PRIMARY RETROPERITONEAL SARCOMA NOT UNDERGO RESECTION? A RETROSPECTIVE SERIES OF 276 PATIENTS TREATED IN TWO SPECIALIZED SARCOMA CENTERS
Rebecca Gladdy
Favorite
Glade Bender, Julia

Memorial Sloan Kettering Cancer Center
Paper 92 - LONG-TERM OUTCOMES IN CHILDREN, ADOLESCENTS, AND YOUNG ADULTS WITH LOCALIZED EWING SARCOMA TREATED WITH IFOSFAMIDE DOSE-INTENSIFICATION
Julia Glade Bender
Favorite
Glosli, H.

Department of Paediatric Research and Department of Paediatric and Adolescent Medicine, Oslo University Hospital
Paper 33 - ASSESSING THE ROLE OF DIFFUSION-WEIGHTED MR IMAGING IN PEDIATRIC AND ADOLESCENT RHABDOMYOSARCOMA: AN INTERNATIONAL RETROSPECTIVE STUDY ON BEHALF OF THE EPSSG IMAGING COMMITTEE
H. Glosli
Favorite
Godwin, J. Luke

Agenus
Paper 58 - A PHASE IA/IB STUDY OF BOTENSILIMAB, A NOVEL INNATE/ADAPTIVE IMMUNE ACTIVATOR, PLUS BALSTILIMAB FOR THE TREATMENT OF PATIENTS WITH SARCOMA
J. Luke Godwin
Favorite
Goel, Neha

University of Miami/Sylvester Comprehensive Cancer Center
Paper 36 - INCREASED PROGRESSION FREE SURVIVAL (PFS) IN ADVANCED GASTROINTESTINAL STROMAL TUMOR (GIST) PATIENTS TREATED WITH SUNITINIB AFTER CIRCULATING TUMOR DNA DETECTION OF A KIT EXON 13 RESISTANCE MUTATION
Neha Goel
Favorite
Gokgoz, Nalan

Lunenfeld-Tanenbaum Research Institute
Paper 35 - DETECTION OF SATELLITE TUMOUR CELLS IN PERI-TUMORAL EDEMA IN INFILTRATIVE SOFT TISSUE SARCOMAS USING A TARGETED MOLECULAR APPROACH
Nalan Gokgoz
Favorite
Gokhale, Prafulla C.

Dana Farber Cancer Institute
Paper 26 - NHEJ DEPENDENCE CREATES THERAPEUTIC VULNERABILITY IN LEIOMYOSARCOMA
Prafulla C. Gokhale
Favorite
González, Jose Antonio

Hospital de La Santa Creu I Sant Pau
Paper 67 - CONVERSION OF RETROPERITONEAL WELL-DIFFERENTIATED TO DEDIFFERENTIATED LIPOSARCOMA: A TARPSWG NATURAL HISTORY STUDY
Jose Antonio González
Favorite
Gonzalez, Felipe

Instituto Nacional de Cancerología
Paper 71 - SUBTYPE-RELATED RESPONSE TO ISOLATED LIMB PERFUSION IN SOFT TISSUE SARCOMAS
Felipe Gonzalez
Favorite
Goodboy, Christine

Children's Hospital of Philadelphia
Paper 92 - LONG-TERM OUTCOMES IN CHILDREN, ADOLESCENTS, AND YOUNG ADULTS WITH LOCALIZED EWING SARCOMA TREATED WITH IFOSFAMIDE DOSE-INTENSIFICATION
Christine Goodboy
Favorite
Gordon, Michael

HonorHealth Research Institute
Paper 58 - A PHASE IA/IB STUDY OF BOTENSILIMAB, A NOVEL INNATE/ADAPTIVE IMMUNE ACTIVATOR, PLUS BALSTILIMAB FOR THE TREATMENT OF PATIENTS WITH SARCOMA
Michael Gordon
Favorite
Gordon, Nancy

The University of Texas MD Anderson Cancer Center
Paper 89 - A PHASE 1/2 TRIAL OF GEMCITABINE, DOCETAXEL, AND HYDROXYCHLOROQUINE IN ADVANCED/METASTATIC OSTEOSARCOMA: RESULTS OF PHASE 1
Nancy Gordon
Favorite
Gorlick, Richard

MD Anderson Cancer Center
Paper 89 - A PHASE 1/2 TRIAL OF GEMCITABINE, DOCETAXEL, AND HYDROXYCHLOROQUINE IN ADVANCED/METASTATIC OSTEOSARCOMA: RESULTS OF PHASE 1
Richard Gorlick
Favorite
Paper 91 - FACTORS ASSOCIATED WITH LOCAL CONTROL AND SURVIVAL IN LOCALIZED EWING SARCOMA PATIENTS: A REPORT FROM THE CHILDREN'S ONCOLOGY GROUP
Richard Gorlick
Favorite
Goto, Koichi

National Cancer Center Hospital East
Paper 23 - UPDATED EFFICACY AND SAFETY OF ENTRECTINIB IN PATIENTS WITH NTRK FUSION-POSITIVE SARCOMAS
Koichi Goto
Favorite
Goulding, Krista

Department of Orthopedic Surgery, Mayo Clinic
Paper 85 - MEANINGFUL INTERPRETATION OF TORONTO EXTREMITY SALVAGE SCORE IN PEOPLE WITH SOFT-TISSUE SARCOMA USING RASCH ANALYSIS
Krista Goulding
Favorite
Gounder, Mrinal

Memorial Sloan Kettering Cancer Center and Weill Cornell Medical Center
Paper 19 - A PHASE IA/IB, DOSE-ESCALATION/EXPANSION STUDY OF THE MDM2–P53 ANTAGONIST BI 907828 IN PATIENTS WITH SOLID TUMORS, INCLUDING ADVANCED/METASTATIC LIPOSARCOMA
Mrinal Gounder
Favorite
Paper 20 - SUSTAINED DISEASE CONTROL WITH MDM2 INHIBITOR MILADEMETAN IN PATIENTS WITH ADVANCED DEDIFFERENTIATED LIPOSARCOMA
Mrinal Gounder
Favorite
Paper 80 - DEFI: A PHASE 3, RANDOMIZED, DOUBLE-BLIND TRIAL OF NIROGACESTAT VERSUS PLACEBO FOR PROGRESSING DESMOID TUMORS/AGGRESSIVE FIBROMATOSIS
Mrinal Gounder
Favorite
Paper 81 - PSYCHOMETRIC PROPERTIES AND MEANINGFUL CHANGE THRESHOLDS (MCT) OF THE GOUNDER/DESMOID TUMOR RESEARCH FOUNDATION DESMOID SYMPTOM/IMPACT SCALE (GODDESS) AS ASSESSED IN THE PHASE 3 DEFI TRIAL
Mrinal Gounder
Favorite
Paper 94 - GENOMIC ALTERATIONS OF DNA DAMAGE REPAIR PATHWAYS IN CHORDOMA: AN ANALYSIS FROM THE AACR-GENIE DATABASE
Mrinal Gounder
Favorite
Grünhagen, Dirk

Erasmus Medical Center
Paper 71 - SUBTYPE-RELATED RESPONSE TO ISOLATED LIMB PERFUSION IN SOFT TISSUE SARCOMAS
Dirk Grünhagen
Favorite
Paper 77 - ACTIVE SURVEILLANCE IN PATIENTS WITH DESMOID-TYPE FIBROMATOSIS: A COMBINED ANALYSIS OF TWO PROSPECTIVE OBSERVATIONAL STUDIES
Dirk Grünhagen
Favorite
Griffin, Anthony

Mount Sinai Hospital
Paper 42 - WHAT FACTORS DIFFERENTIATE EARLY VERSUS LATE PULMONARY METASTASES IN SOFT TISSUE SARCOMA OF THE EXTREMITIES? A COMPARATIVE COHORT ANALYSIS
Anthony Griffin
Favorite
Paper 69 - MAPPING THE COURSE OF RECOVERY FOLLOWING LIMB SALVAGE SURGERY FOR SOFT TISSUE SARCOMA OF THE EXTREMITIES
Anthony Griffin
Favorite
Paper 75 - SURGICAL FACTORS TO PREDICT POSTOPERATIVE WOUND COMPLICATIONS IN LOCALIZED SOFT-TISSUE SARCOMAS OF THE EXTREMITY
Anthony Griffin
Favorite
Griffin, Katherine

University of California, Davis
Paper 31 - ENGINEERED BONE MARROW: A COMPLEX MODEL FOR PRIMARY OSTEOSARCOMA TUMORIGENESIS
Katherine Griffin
Favorite
Griffiths, Pip

IQVIA
Paper 81 - PSYCHOMETRIC PROPERTIES AND MEANINGFUL CHANGE THRESHOLDS (MCT) OF THE GOUNDER/DESMOID TUMOR RESEARCH FOUNDATION DESMOID SYMPTOM/IMPACT SCALE (GODDESS) AS ASSESSED IN THE PHASE 3 DEFI TRIAL
Pip Griffiths
Favorite
Grignani, Giovanni

Department of Medical Oncology-Sarcoma Unit, Candiolo Cancer Institute FPO-IRCCS, Candiolo (TO), Italy
Paper 01 - CREATION AND IMPLEMENTATION OF A MONTHLY INTERNATIONAL TUMOR BOARD: EXPERIENCE OF THE TRANSATLANTIC AUSTRALASIAN RETROPERITONEAL SARCOMA WORKING GROUP (TARPSWG)
Giovanni Grignani
Favorite
Paper 43 - A NOVEL PROGNOSTICATION SYSTEM FOR PATIENTS WITH HIGH-RISK KIT EXON 9-MUTATED GASTROINTESTINAL STROMAL TUMOUR RECEIVING ADJUVANT IMATINIB
Giovanni Grignani
Favorite
Paper 77 - ACTIVE SURVEILLANCE IN PATIENTS WITH DESMOID-TYPE FIBROMATOSIS: A COMBINED ANALYSIS OF TWO PROSPECTIVE OBSERVATIONAL STUDIES
Giovanni Grignani
Favorite
Gronchi, Alessandro

Fondazione IRCCS Istituto Nazionale dei Tumori
Mentorship Session 5: Setting Up Collaborations in Rare Tumors
Alessandro Gronchi
Favorite
Paper 01 - CREATION AND IMPLEMENTATION OF A MONTHLY INTERNATIONAL TUMOR BOARD: EXPERIENCE OF THE TRANSATLANTIC AUSTRALASIAN RETROPERITONEAL SARCOMA WORKING GROUP (TARPSWG)
Alessandro Gronchi
Favorite
Paper 43 - A NOVEL PROGNOSTICATION SYSTEM FOR PATIENTS WITH HIGH-RISK KIT EXON 9-MUTATED GASTROINTESTINAL STROMAL TUMOUR RECEIVING ADJUVANT IMATINIB
Alessandro Gronchi
Favorite
Paper 63 - DO EARLY RECURRENT PRIMARY RETROPERITONEAL SARCOMA (RPS) HAVE SIMILAR SURVIVAL TO INOPERABLE RPS: WAS SURGERY WORTHY?
Alessandro Gronchi
Favorite
Paper 65 - IDENTIFICATION OF A GENOMIC SIGNATURE THAT IMPROVES THE PERFORMANCE OF THE SARCULATOR NOMOGRAM FOR PATIENTS WITH PRIMARY RETROPERITONEAL SARCOMA
Alessandro Gronchi
Favorite
Paper 67 - CONVERSION OF RETROPERITONEAL WELL-DIFFERENTIATED TO DEDIFFERENTIATED LIPOSARCOMA: A TARPSWG NATURAL HISTORY STUDY
Alessandro Gronchi
Favorite
Paper 77 - ACTIVE SURVEILLANCE IN PATIENTS WITH DESMOID-TYPE FIBROMATOSIS: A COMBINED ANALYSIS OF TWO PROSPECTIVE OBSERVATIONAL STUDIES
Alessandro Gronchi
Favorite
Gross, Amy

Center for Childhood Cancer, Nationwide Children's Hospital
Paper 14 - TUMOR-TUMOR COOPERATION DURING OSTEOSARCOMA LUNG METASTASIS IS DRIVEN BY EPITHELIAL INTERACTIONS WITH NICHE-INITIATING ANCHOR CELLS
Amy Gross
Favorite
Grossman, Joseph

Agenus
Paper 58 - A PHASE IA/IB STUDY OF BOTENSILIMAB, A NOVEL INNATE/ADAPTIVE IMMUNE ACTIVATOR, PLUS BALSTILIMAB FOR THE TREATMENT OF PATIENTS WITH SARCOMA
Joseph Grossman
Favorite
Groundland, John

Huntsman Cancer Institute
Paper 74 - TOTAL SIZE OF POST-OPERATIVE SEROMA CORRELATES WITH WOUND COMPLICATIONS FOLLOWING SOFT-TISSUE SARCOMA RESECTION
John Groundland
Favorite
Guadagnolo, B. Ashleigh

MDACC
Session 6: Radiation Oncology & Oligometastatic Disease
Location: VCC, East Exhibition Hall A
B. Ashleigh Guadagnolo
Favorite
Guan, Peiyong

Genome Institute of Singapore
Paper 15 - SPATIAL TRANSCRIPTOMICS REVEAL TOPOLOGICAL IMMUNE LANDSCAPES OF ASIAN HEAD AND NECK ANGIOSARCOMA
Peiyong Guan
Favorite
Guedes, Brian

Duke University School of Medicine
Paper 28 - CYCLIN DEPENDENT KINASE 8: A PHARMACOLOGIC TARGET FOR FUSION-POSITIVE RHABDOMYOSARCOMA
Brian Guedes
Favorite
Guinot, Aurélie

institut d'oncologie et hématologie pédiatrique
Paper 90 - STAGING OF NEWLY DIAGNOSED EWING SARCOMA: RESULTS OF BONE MARROW ASPIRATION AND BIOPSY VERSUS (18) FDG-PET SCAN FOR BONE MARROW INVOLVEMENT
Aurélie Guinot
Favorite
Gulamhusein, Aziz

The Christie NHS Foundation Trust
Paper 64 - PRIMARY RETROPERITONEAL SARCOMA: VARIABILITY OF RESECTABILITY AND TREATMENT ALLOCATION DURING MULTIDISCIPLINARY TEAM MEETING ASSESSMENTS IN ENGLAND
Aziz Gulamhusein
Favorite
Gulia, Aashish

Tata Memorial Centre
Paper 79 - EVALUATION OF METRONOMIC THERAPY AS A LOW-COST, SUSTAINABLE STANDARD OF CARE OPTION IN DESMOID FIBROMATOSIS: REAL WORLD DATA FROM A TERTEARY CARE CENTRE IN INDIA
Aashish Gulia
Favorite
Gundavda, Manit

Kokilaben Dhirubhai Ambani Hospital, Mumbai, India
Paper 42 - WHAT FACTORS DIFFERENTIATE EARLY VERSUS LATE PULMONARY METASTASES IN SOFT TISSUE SARCOMA OF THE EXTREMITIES? A COMPARATIVE COHORT ANALYSIS
Manit Gundavda
Favorite
Paper 69 - MAPPING THE COURSE OF RECOVERY FOLLOWING LIMB SALVAGE SURGERY FOR SOFT TISSUE SARCOMA OF THE EXTREMITIES
Manit Gundavda
Favorite
Paper 75 - SURGICAL FACTORS TO PREDICT POSTOPERATIVE WOUND COMPLICATIONS IN LOCALIZED SOFT-TISSUE SARCOMAS OF THE EXTREMITY
Manit Gundavda
Favorite
Gundle, Kenneth

Oregon Health & Science University | Portland VA Medical Center
Paper 84 - NATURAL LANGUAGE PROCESSING OF PATHOLOGY REPORTS IDENTIFIES SOFT TISSUE SARCOMAS MISSED BY INTERNATIONAL CLASSIFICATION OF DISEASES CODES IN THE VA NATIONAL DATABASE
Kenneth Gundle
Favorite
Gunther, Kate

Children's Cancer Institute
Paper 27 - MULTI-PLATFORM TYROSINE KINASE PROFILING REVEALS NOVEL ACTIONABLE FGFR ABERRATIONS ACROSS PEDIATRIC AND ADOLESCENT AND YOUNG ADULT SARCOMAS
Kate Gunther
Favorite
Gupta, Abha

Division of Hematology/Oncology, Hospital for Sick Children, University of Toronto, Ontario, Canada; Division of Medical Oncology, Princess Margaret Cancer Centre, University of Toronto, Ontario, Canada; CanSaRCC, Princess Margaret Cancer Center, Ontario, Canada
Mentorship Session 4: Program Development: Starting Sarcoma Programs to Growing Established Programs
Abha Gupta
Favorite
Session 13: Epidemiology, Informatics, Population Health, Health Outcomes
Location: VCC, East Exhibition Hall A
Abha Gupta
Favorite
Paper 03 - ASSESSING THE VALUE OF A NATIONAL SARCOMA GOOGLE GROUP FOR CANADIAN MEDICAL ONCOLOGISTS IN THE MANAGEMENT OF SARCOMA
Abha Gupta
Favorite
Gupta, Gaurav

Tata Memorial Centre
Paper 79 - EVALUATION OF METRONOMIC THERAPY AS A LOW-COST, SUSTAINABLE STANDARD OF CARE OPTION IN DESMOID FIBROMATOSIS: REAL WORLD DATA FROM A TERTEARY CARE CENTRE IN INDIA
Gaurav Gupta
Favorite
Gupta, Sudeep

Tata Memorial Centre
Paper 79 - EVALUATION OF METRONOMIC THERAPY AS A LOW-COST, SUSTAINABLE STANDARD OF CARE OPTION IN DESMOID FIBROMATOSIS: REAL WORLD DATA FROM A TERTEARY CARE CENTRE IN INDIA
Sudeep Gupta
Favorite
Gyorki, David

Peter MacCallum Cancer Centre
Session 10: Retroperitoneal and Abdominal Sarcomas
Location: VCC, East Exhibition Hall A
David Gyorki
Favorite
Paper 67 - CONVERSION OF RETROPERITONEAL WELL-DIFFERENTIATED TO DEDIFFERENTIATED LIPOSARCOMA: A TARPSWG NATURAL HISTORY STUDY
David Gyorki
Favorite